Frank DeBenedittis - Aceto Insider

ACET -- USA Stock  

USD 4.00  0.06  1.48%

Sr. VP of Corporate Bus. Devel. and International Sr. VP of Active Pharmaceutical Ingredients

Mr. Frank V. DeBenedittis is Senior Vice President Corporationrationrate Business Development of Aceto Corporationration He has served as Senior Vice President, Corporationrationrate Business Development since August 2011 and International Senior Vice President, Active Pharmaceutical Ingredients since February 2011. Prior to that, Mr. DeBenedittis was Executive Vice President since January 2009 and Senior Vice President of the Company since 2001. Mr. DeBenedittis joined the Company in 1979 as a marketing assistant and held various positions within the Company including Assistant Product Manager, Product Manager, Assistant Vice President and Vice President. In addition, Mr. DeBenedittis currently serves on the board of directors of Rising Pharmaceuticals, Inc., a wholly owned subsidiary of the Company
Age: 60  SVP Since 2011      
516-627-6000  http://www.aceto.com
DeBenedittis holds a B.A. in Chemistry from Stony Brook University.

Frank DeBenedittis Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 1.46 % which means that it generated profit of $1.46 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (68.72) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 319.42 M in liabilities with Debt to Equity (D/E) ratio of 157.0 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Aceto Corporation has Current Ratio of 1.1 suggesting that it is in a questionable position to pay out its financial obligations when they are due.

Similar Executives

Found 6 records

SVP Since

Darin TangVeritiv Corporation
2014
Loriann SheltonVOXX International Corporation
2016
Kent YeeDXP Enterprises
2017
Todd HamlinDXP Enterprises
2017
Thomas LazzaroVeritiv Corporation
2014
Joseph MyersVeritiv Corporation
2014

Entity Summary

Aceto Corporation, together with its subsidiaries, sources, markets, sells, and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products, and specialty chemicals. Aceto Corporation was founded in 1947 and is headquartered in Port Washington, New York. Aceto operates under Drug Manufacturers - Specialty Generic classification in USA and traded on NASDAQ. It employs 286 people.Aceto Corporation (ACET) is traded on NASDAQ in USA. It is located in NEW YORK, U.S.A and employs 286 people. Aceto is listed under Wholesale category by Fama And French industry classification.

Aceto Leadership Team

Edward Borkowski, CFO, MBA
Rebecca Roof, CFO
Hans Noetzli, Director
Douglas Roth, CFO, MBA
Natasha Giordano, Director
Alan Levin, Director
Daniel Yarosh, Director, Ph.D
Salvatore Guccione, CEO
Albert Eilender, Chairman
Jody Burfening, Executive
William Britton, Director
Terry Kippley, President, MBA
Frances Scally, Executive
Satish Srinivasan, President, MBA
Frank DeBenedittis, SVP
Richard Randall, Director
Carlos Restrepo, President
Vimal Kavuru, President
Nicholas Shackley, President
Steven Rogers, SVP
Walter Kaczmarek, COO
William Kennally, Director
Charles Alaimo, President
Fran Scally, Executive
Raymond Bartone, President

Stock Performance Indicators

Did you try this?

Run Money Managers Now
   

Money Managers

Screen money managers from public funds and ETFs managed around the world
All  Next Launch Money Managers

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Aceto and Adams Resources Energy. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Companies Directory module to evaluate performance of over 100,000 stocks, funds, and etfs against different fundamentals.